133 related articles for article (PubMed ID: 7554110)
1. Adrenomedullin as a novel antimigration factor of vascular smooth muscle cells.
Horio T; Kohno M; Kano H; Ikeda M; Yasunari K; Yokokawa K; Minami M; Takeda T
Circ Res; 1995 Oct; 77(4):660-4. PubMed ID: 7554110
[TBL] [Abstract][Full Text] [Related]
2. Natriuretic peptide family as a novel antimigration factor of vascular smooth muscle cells.
Ikeda M; Kohno M; Yasunari K; Yokokawa K; Horio T; Ueda M; Morisaki N; Yoshikawa J
Arterioscler Thromb Vasc Biol; 1997 Apr; 17(4):731-6. PubMed ID: 9108787
[TBL] [Abstract][Full Text] [Related]
3. Adrenomedullin is a potent inhibitor of angiotensin II-induced migration of human coronary artery smooth muscle cells.
Kohno M; Yokokawa K; Kano H; Yasunari K; Minami M; Hanehira T; Yoshikawa J
Hypertension; 1997 Jun; 29(6):1309-13. PubMed ID: 9180634
[TBL] [Abstract][Full Text] [Related]
4. Regulation of rat mesangial cell migration by platelet-derived growth factor, angiotensin II, and adrenomedullin.
Kohno M; Yasunari K; Minami M; Kano H; Maeda K; Mandal AK; Inoki K; Haneda M; Yoshikawa J
J Am Soc Nephrol; 1999 Dec; 10(12):2495-502. PubMed ID: 10589687
[TBL] [Abstract][Full Text] [Related]
5. Inhibition of endothelin production by adrenomedullin in vascular smooth muscle cells.
Kohno M; Kano H; Horio T; Yokokawa K; Yasunari K; Takeda T
Hypertension; 1995 Jun; 25(6):1185-90. PubMed ID: 7768561
[TBL] [Abstract][Full Text] [Related]
6. Induction by lysophosphatidylcholine, a major phospholipid component of atherogenic lipoproteins, of human coronary artery smooth muscle cell migration.
Kohno M; Yokokawa K; Yasunari K; Minami M; Kano H; Hanehira T; Yoshikawa J
Circulation; 1998 Jul; 98(4):353-9. PubMed ID: 9711941
[TBL] [Abstract][Full Text] [Related]
7. Inhibition of vascular smooth muscle cell migration by cytochrome p450 epoxygenase-derived eicosanoids.
Sun J; Sui X; Bradbury JA; Zeldin DC; Conte MS; Liao JK
Circ Res; 2002 May; 90(9):1020-7. PubMed ID: 12016269
[TBL] [Abstract][Full Text] [Related]
8. Adrenomedullin as a novel antiproliferative factor of vascular smooth muscle cells.
Kano H; Kohno M; Yasunari K; Yokokawa K; Horio T; Ikeda M; Minami M; Hanehira T; Takeda T; Yoshikawa J
J Hypertens; 1996 Feb; 14(2):209-13. PubMed ID: 8728298
[TBL] [Abstract][Full Text] [Related]
9. Red wine polyphenols inhibit vascular smooth muscle cell migration through two distinct signaling pathways.
Iijima K; Yoshizumi M; Hashimoto M; Akishita M; Kozaki K; Ako J; Watanabe T; Ohike Y; Son B; Yu J; Nakahara K; Ouchi Y
Circulation; 2002 May; 105(20):2404-10. PubMed ID: 12021228
[TBL] [Abstract][Full Text] [Related]
10. Heparan sulfate proteoglycans mediate a potent inhibitory signal for migration of vascular smooth muscle cells.
Koyama N; Kinsella MG; Wight TN; Hedin U; Clowes AW
Circ Res; 1998 Aug; 83(3):305-13. PubMed ID: 9710123
[TBL] [Abstract][Full Text] [Related]
11. Interaction of adrenomedullin and platelet-derived growth factor on rat mesangial cell production of endothelin.
Kohno M; Yasunari K; Yokokawa K; Horio T; Ikeda M; Kano H; Minami M; Hanehira T; Yoskikawa J
Hypertension; 1996 Mar; 27(3 Pt 2):663-7. PubMed ID: 8613221
[TBL] [Abstract][Full Text] [Related]
12. Dopamine as a novel antimigration and antiproliferative factor of vascular smooth muscle cells through dopamine D1-like receptors.
Yasunari K; Kohno M; Hasuma T; Horio T; Kano H; Yokokawa K; Minami M; Yoshikawa J
Arterioscler Thromb Vasc Biol; 1997 Nov; 17(11):3164-73. PubMed ID: 9409307
[TBL] [Abstract][Full Text] [Related]
13. Effects of dominant-negative c-Jun on platelet-derived growth factor-induced vascular smooth muscle cell proliferation.
Zhan Y; Kim S; Yasumoto H; Namba M; Miyazaki H; Iwao H
Arterioscler Thromb Vasc Biol; 2002 Jan; 22(1):82-8. PubMed ID: 11788465
[TBL] [Abstract][Full Text] [Related]
14. Litebamine, a phenanthrene alkaloid from the wood of Litsea cubeba, inhibits rat smooth muscle cell adhesion and migration on collagen.
Huang CH; Huang WJ; Wang SJ; Wu PH; Wu WB
Eur J Pharmacol; 2008 Oct; 596(1-3):25-31. PubMed ID: 18773889
[TBL] [Abstract][Full Text] [Related]
15. Arachidonic acid pretreatment enhances smooth muscle cell migration via increased Ca2+ influx.
Kanayasu-Toyoda T; Morita I; Murota S
Prostaglandins Leukot Essent Fatty Acids; 1998 Jan; 58(1):25-31. PubMed ID: 9482163
[TBL] [Abstract][Full Text] [Related]
16. Differences in cellular responses to mitogens in arterial smooth muscle cells derived from patients with moyamoya disease.
Yamamoto M; Aoyagi M; Fukai N; Matsushima Y; Yamamoto K
Stroke; 1998 Jun; 29(6):1188-93. PubMed ID: 9626293
[TBL] [Abstract][Full Text] [Related]
17. Platelet-derived growth factor-BB (PDGF-BB) regulation of migration and focal adhesion kinase phosphorylation in rabbit aortic vascular smooth muscle cells: roles of phosphatidylinositol 3-kinase and mitogen-activated protein kinases.
Cospedal R; Abedi H; Zachary I
Cardiovasc Res; 1999 Mar; 41(3):708-21. PubMed ID: 10435043
[TBL] [Abstract][Full Text] [Related]
18. Heparin inhibits human coronary artery smooth muscle cell migration.
Kohno M; Yokokawa K; Yasunari K; Minami M; Kano H; Mandal AK; Yoshikawa J
Metabolism; 1998 Sep; 47(9):1065-9. PubMed ID: 9751234
[TBL] [Abstract][Full Text] [Related]
19. A novel adipocytokine, omentin, inhibits platelet-derived growth factor-BB-induced vascular smooth muscle cell migration through antioxidative mechanism.
Kazama K; Okada M; Yamawaki H
Am J Physiol Heart Circ Physiol; 2014 Jun; 306(12):H1714-9. PubMed ID: 24727494
[TBL] [Abstract][Full Text] [Related]
20. Endothelial nitric oxide synthase gene transfer inhibits human smooth muscle cell migration via inhibition of Rho A.
Largiadèr T; Eto M; Payeli SK; Greutert H; Viswambharan H; Lachat M; Zünd G; Yang Z; Tanner FC; Lüscher TF
J Cardiovasc Pharmacol; 2008 Oct; 52(4):369-74. PubMed ID: 18841072
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
